Abstract
Objectives: Ovarian cancer is represented in different hereditary cancer syndromes, including hereditary breast and ovarian cancer (HBOC) caused by mutations in BRCA1 and BRCA2 and Lynch syndrome (LS) caused by mutations in MLH1, MSH2, MSH6, PMS2, and EPCAM. Recently, mutations in other genes have been identified as increasing ovarian cancer risk, including RAD51C, RAD51D, and BRIP1. This analysis describes the genetic testing results for patients with ovarian cancer tested with a 25-gene hereditary cancer panel.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
